SEMGLEE® and Insulin Glargine (insulin glargine-yfgn) injection
Individualize and adjust the dosage of SEMGLEE based on the
individual’s metabolic needs, blood glucose monitoring results and
glycemic control goal.
Type 1 Diabetes
- In patients with type 1 diabetes, SEMGLEE must be used concomitantly with
short-acting insulin. The recommended starting dose of SEMGLEE in patients
with type 1 diabetes should be approximately one-third of the total daily
insulin requirements. Short-acting, premeal insulin should be used to
satisfy the remainder of the daily insulin requirements.
Type 2 Diabetes
- The recommended starting dose of SEMGLEE in patients with type 2 diabetes
who are not currently treated with insulin is 0.2 units/kg or up to 10 units
once daily. One may need to adjust the amount and timing of short-or
rapid-acting insulins and dosages of other antidiabetic drugs.